Johnson & Johnson (NYSE:JNJ)

During the Trading Day
102.30 +0.34 / +0.33%
Data as of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
102.37 +0.07 / +0.07%
 
Volume: 84.8K
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds
3:20pm / Zacks.com
Is Alkermes plc Stock Undervalued?
Jul 22 / MotleyFool.com
Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary
2:47pm / Zacks.com
3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Jul 22 / MotleyFool.com
Hospira Beats on Earnings and Sales in Q2, Boosts Guidance - Analyst Blog
11:58am / Zacks.com
Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
Jul 22 / MotleyFool.com
Top 3 MedTech Stocks, Poised to Gain on Earnings - Earnings ESP
Jul 29 / Zacks.com
Tuesdaybs Top Health Care Stocks: Herbalife, Exact Sciences, AstraZeneca, J&J
Jul 22 / MotleyFool.com
Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog
Jul 28 / Zacks.com
1 Key Way Obamacare Could Help Johnson & Johnson Stock
Jul 21 / MotleyFool.com
3 Stocks Reiterated As A Buy: MDLZ, HAL, JNJ
Jul 28 / TheStreet.com
Dow 30 Stock Roundup: INTC, JPM, JNJ Beat Estimates, MSFT to Cut 18K Jobs - Analyst B...
Jul 21 / Zacks.com
What Makes Johnson & Johnson a Healthy Dividend Investment
Jul 28 / TheStreet.com
Company Notes Digest 7.18.14
Jul 18 / StockTwits
Consumer and pharma groups swap assets
Jul 28 / FT.com
How the Dow's Pharma Stocks Helped Boost Markets Friday
Jul 18 / MotleyFool.com
L'OrC)al make-up goes virtual for the selfie age
Jul 28 / FT.com
3 Crucial Questions Johnson & Johnson Needs to Answer
Jul 18 / MotleyFool.com
Frontrunning: July 28
Jul 28 / Investing Channel
What You Need to Know About Johnson & Johnson's Best-Selling Drugs
Jul 18 / MotleyFool.com
Humira Still Key to AbbVie
Jul 25 / MotleyFool.com
What Johnson & Johnson Needs to Take the Stock Higher
Jul 18 / MotleyFool.com
Why Gilead Stock's Newest Drug Approval Isn't a Gamechanger
Jul 25 / MotleyFool.com
Stryker Q2 Earnings Rise Marginally, Lag Estimates - Analyst Blog
Jul 18 / Zacks.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews
Jul 24 / Zacks.com
Do Johnson & Johnson's Results Suggest a Pop or Drop for Gilead Sciences?
Jul 17 / MotleyFool.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
Jul 24 / Zacks.com
Why Johnson & Johnson Keeps Defying Gravity
Jul 17 / MotleyFool.com
Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
Jul 24 / Zacks.com
A Good Start to Q2 Earnings Season - Earnings Trends
Jul 17 / Zacks.com
Why Organovo Holdings Inc Stock Bulked Up Today
Jul 24 / MotleyFool.com
A Good Start to Q2 Earnings Season - Earnings Trends
Jul 16 / Zacks.com
Organovo Up 19% #PreMarket; In Research Pact With Johnson & Johnson Unit
Jul 24 / Benzinga
Keep Calm and Carry On, J&J
Jul 16 / MotleyFool.com
Why Covidien Stock Is Still Undervalued Despite the Medtronic Deal
Jul 24 / TheStreet.com
Healthcare ETFs in Focus on JNJ Earnings - ETF News And Commentary
Jul 16 / Zacks.com
Invest In These Alternatives To Biotech
Jul 23 / Investing Channel
Johnson and Johnson, Inc. (JNJ): New Analyst Report from Zacks Equity Research - Zack...
Jul 16 / Zacks.com
What Will Puma Biotechnology Inc's $700 Million Man Do Next?
Jul 23 / MotleyFool.com
A Surprising Johnson & Johnson Stock Growth Driver, Revealed
Jul 16 / MotleyFool.com
Is Gilead About to Crush Pharmacyclics Stock?
Jul 23 / MotleyFool.com
Americans stock up on Tylenol, baby products
Jul 15 / CNNMoney.com
Why the Market Is Wrong About Intuitive Surgical Stock
Jul 23 / MotleyFool.com
Stocks: 4 things to know before the open
Jul 15 / CNNMoney.com
Follow Goldman Sachs Group Inc With These Equity ETFs
Jul 23 / Investing Channel
Trader focus turns to Yellen testimony
Jul 15 / FT.com
Stock Market News for July 23, 2014 - Market News
Jul 23 / Zacks.com
Low volatility is bad for 'low-vol' funds
Jul 09 / FT.com
Johnson & Johnson Announces $5B Share Buyback - Analyst Blog
Jul 22 / Zacks.com
Roche to buy US cancer drug group Seragon
Jul 02 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.